Form D · Biotechnology
Redwood Scientific Technologies, Inc.
Albany, NY · CIK 0001634394
Offering snapshot reported Jul 11, 2023 · SEC filing
- Reported sold
- $1.14M Offering amount: $1.14M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 4, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 11, 2023 | Initial | $1,140,000 | No comparison | 13 | SEC filing |
| Jan 28, 2016 | Amendment | $3,441,253 | $2,941,253vs May 15, 2015 | 35 | SEC filing |
| May 15, 2015 | Initial | $500,000 | No comparison | 3 | SEC filing |
| Feb 19, 2015 | Initial | $1,065,000 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-486448
Source: Form D, filed Jul 11, 2023. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Eunjung Cardiff | Director |
| Jason Cardiff | Director, Executive |
| David Duncan | Executive |
| Kevin Harrington | Director |
| John Harrington | Executive |
| Christine Hayes | Director |
| Cardiff Jason | Director, Executive |
| Brian Kennedy | Director |
| Patrick Moynihan | Director |
| Jacques Poujade | Director |
| Jaci Warren | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
418 Broadway Suite 4872
Albany, NY, 12207
Albany, NY, 12207